Advertisement

Topics

OCTIMET Oncology NV awarded €1.12 million grant from VLAIO

01:00 EST 9 Nov 2017 | Bionity

OCTIMET Oncology NV, based at the JLINX facility in Beerse, Belgium, with a focus on the development of selective MET kinase inhibitory drug candidates, today announced it has received a €1.12 million grant from VLAIO, the Flanders organization for Innovation & Entrepreneurship, former IWT. OCTIMET ...

Original Article: OCTIMET Oncology NV awarded €1.12 million grant from VLAIO

NEXT ARTICLE

More From BioPortfolio on "OCTIMET Oncology NV awarded €1.12 million grant from VLAIO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...